Imdusiran

AB-729 · Arbutus Biopharma Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Imdusiran, covering 2024-08-12 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)